natgillin/translations-raw huggingface dataset:
for the specific supply arrangements, analysis of the proportionality of the aid in relation to the additional cost of transport to the smaller Aegean islands and, in the case of products intended for processing and agricultural inputs, the additional costs of insularity and distant location;
za posebne režime preskrbe: analiza sorazmernosti pomoči glede na dodatne stroške prevoza na manjše egejske otoke, v primeru proizvodov za predelavo in kmetijskih vložkov pa tudi dodatni stroški zaradi otoške lege in oddaljenosti;
annual data on the common performance indicators referred to in Article 29 of this Regulation and their analysis in particular with regard to the attainment of the general objectives set out in Article 2 of Regulation (EU) No 229/2013.
letni podatki o skupnih kazalnikih uspešnosti iz člena 29 te uredbe in njihova analiza, zlasti pri doseganju splošnih ciljev iz člena 2 Uredbe (EU) št. 229/2013.
Conclusions of the analyses on the suitability of the strategy of the measures and its possible improvement in order to achieve the objectives of the programme.
Zaključki analize ustreznosti strategije za izvedbo ukrepov in njene morebitne izboljšave, da bi se dosegli cilji programa.
Brief account of any major problems encountered in managing and implementing the measures during the year in question.
Kratka predstavitev vseh večjih težav pri upravljanju in izvajanju ukrepov v zadevnem letu.
Statistics on the checks carried out by the competent authorities and any penalties applied.
Statistični podatki o preverjanjih, ki so jih izvedli pristojni organi, ter morebitne naložene kazni.
Any additional information that could be useful for the understanding of the data submitted.
Kakršne koli dodatne informacije, ki bi lahko bile koristne za razumevanje predloženih podatkov.
Brief summary of any amendments to the programme presented during the year in question and their justifications.
Kratek povzetek vseh sprememb programa, ki so bile predložene v zadevnem letu, in njihova utemeljitev.
Commission Implementing Regulation (EU) 2018/917
Izvedbena uredba Komisije (EU) 2018/917
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor
o spremembi Izvedbene Uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi alfa-cipermetrin, beflubutamid, benalaksil, bentiavalikarb, bifenazat, boskalid, bromoksinil, kaptan, karvon, klorprofam, ciazofamid, desmedifam, dimetoat, dimetomorf, dikvat, etefon, etoprofos, etoksazol, famoksadon, fenamidon, fenamifos, flumioksazin, fluoksastrobin, folpet, foramsulfuron, formetanat, Gliocladium catenulatum sev: J1446, izoksaflutol, metalaksil-m, metiokarb, metoksifenozid, metribuzin, milbemektin, oksasulfuron, Paecilomyces lilacinus sev 251, fenmedifam, fosmet, pirimifos-metil, propamokarb, protiokonazol, pimetrozin in S-metolaklor
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular the first paragraph of Article 17 thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS ter zlasti prvega odstavka člena 17 Uredbe,
The approval periods of the active substances diquat, famoxadone, flumioxazine, metalaxyl-m and pymetrozine were last extended by Commission Implementing Regulation (EU) 2017/841.
Obdobja odobritve aktivnih snovi dikvat, famoksadon, flumioksazin, metalaksil-M in pimetrozin so bila nazadnje podaljšana z Izvedbeno uredbo Komisije (EU) 2017/841.
Applications for the renewal of the inclusion of those substances in Annex I to Council Directive 91/414/EEC were submitted in accordance with Article 4 of Commission Regulation (EU) No 1141/2010.
Obdobji odobritve navedenih snovi bosta prenehali veljati 31. julija 2018.
The approval periods of the active substances alpha-cypermethrin, benalaxyl, bifenazate, bromoxynil, chlorpropham, cyazofamid, desmedipham, etoxazole, fenamidone, foramsulfuron, Gliocladium catenulatum strain: J1446, isoxaflutole, methoxyfenozide, milbemectin, oxasulfuron, phenmedipham and s-metolachlor were last extended by Implementing Regulation (EU) 2017/841.
Obdobja odobritve aktivnih snovi beflubutamid, kaptan, dimetoat, dimetomorf, etoprofos, folpet, formetanat, metiokarb, metribuzin, fosmet, pirimifos-metil in propamokarb so bila podaljšana z Izvedbeno uredbo Komisije (EU) 2015/404.
The approval periods of those substances will expire on 31 July 2018.
Obdobji odobritve aktivnih snovi etefon in fenamifos sta bili podaljšani z Izvedbeno uredbo Komisije (EU) 2015/415.
The approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, folpet, formetanate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb were extended by Commission Implementing Regulation (EU) 2015/404.
Obdobja odobritve aktivnih snovi bentiavalikarb, boskalid, karvon, fluoksastrobin, Paecilomyces lilacinus sev 251 in protiokonazol bodo prenehala veljati 31. julija 2018.
The approval periods of the active substances ethephon and fenamiphos were extended by Commission Implementing Regulation (EU) 2015/415.
Vloge za obnovitev odobritve snovi iz uvodnih izjav 3–5 so bile vložene v skladu z Izvedbeno uredbo Komisije (EU) št. 844/2012.
The approval periods of the active substances benthiavalicarb, boscalid, carvone, fluoxastrobin, Paecilomyces lilacinus strain 251 and prothioconazole will expire on 31 July 2018.
Ker se je ocenjevanje snovi zavleklo iz razlogov, na katere vlagatelji ne morejo vplivati, obstaja možnost, da bodo odobritve navedenih aktivnih snovi potekle pred sprejetjem sklepa o njihovi obnovitvi.
Applications for the renewal of the approval of the substances referred to in recitals 3 to 5 were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012.
Zato je treba podaljšati njihova obdobja odobritve.
Due to the fact that the assessment of the substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal.
Glede na cilj prvega odstavka člena 17 Uredbe (ES) št. 1107/2009 v zvezi s primeri, v katerih Komisija sprejme uredbo, ki določa, da se odobritev aktivne snovi iz Priloge k tej uredbi ne obnovi, ker merila za odobritev niso izpolnjena, Komisija določi isti datum veljavnosti kot pred to uredbo ali datum začetka veljavnosti Uredbe, ki določa, da se odobritev aktivne snovi ne obnovi, odvisno od tega, kateri datum je poznejši.
It is therefore necessary to extend their approval periods.
V zvezi s primeri, v katerih Komisija sprejme uredbo o obnovitvi odobritve aktivne snovi iz Priloge k tej uredbi, bo Komisija poskusila določiti, kot je ustrezno v danih okoliščinah, najzgodnejši možni datum začetka uporabe.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
Ob upoštevanju, da nekaj odobritev aktivnih snovi preneha veljati 30. junija 2018, bi morala ta uredba začeti veljati čim prej.
Taking into account that some of the approvals of the active substances expire on 30 June 2018, this Regulation should enter into force as soon as possible.
Ukrepi iz te uredbe so v skladu z mnenjem Stalnega odbora za rastline, živali, hrano in krmo –
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Ta uredba začne veljati dan po objavi v Uradnem listu Evropske unije.
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
V Bruslju, 27. junija 2018
Done at Brussels, 27 June 2018.
Predsednik
The President
Izvedbena uredba Komisije (EU) št. 540/2011 z dne 25. maja 2011 o izvajanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta glede seznama registriranih aktivnih snovi (UL L 153, 11.6.2011, str. 1).
OJ L 309, 24.11.2009, p. 1.
Izvedbena uredba Komisije (EU) 2017/841 z dne 17. maja 2017 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve aktivnih snovi alfa-cipermetrin, Ampelomyces quisqualis sev: AQ 10, benalaksil, bentazon, bifenazat, bromoksinil, karfentrazon-etil, klorprofam, ciazofamid, desmedifam, dikvat, DPX KE 459 (flupirsulfuron-metil), etoksazol, famoksadon, fenamidon, flumioksazin, foramsulfuron, Gliocladium catenulatum sev: J1446, imazamoks, izoksaflutol, laminarin, metalaksil-M, metoksifenozid, milbemektin, oksasulfuron, pendimetalin, fenmedifam, pimetrozin, S-metolaklor in trifloksistrobin (UL L 125, 18.5.2017, str. 12).
Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin (OJ L 125, 18.5.2017, p. 12).
Uredba Komisije (EU) št. 1141/2010 z dne 7. decembra 2010 o postopku za obnovitev vključitve druge skupine aktivnih snovi v Prilogo I k Direktivi Sveta 91/414/EGS in oblikovanju seznama navedenih snovi (UL L 322, 8.12.2010, str. 10).
Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230, 19.8.1991, p. 1).
Izvedbena uredba Komisije (EU) 2015/404 z dne 11. marca 2015 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve aktivnih snovi beflubutamid, kaptan, dimetoat, dimetomorf, etoprofos, fipronil, folpet, formetanat, glufosinat, metiokarb, metribuzin, fosmet, pirimifos-metil in propamokarb (UL L 67, 12.3.2015, str. 6).
Commission Regulation (EU) No 1141/2010 of 7 December 2010 laying down the procedure for the renewal of the inclusion of a second group of active substances in Annex I to Council Directive 91/414/EEC and establishing the list of those substances (OJ L 322, 8.12.2010, p. 10).
Izvedbena uredba Komisije (EU) 2015/415 z dne 12. marca 2015 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja veljavnosti registracije aktivnih snovi etefon in fenamifos (UL L 68, 13.3.2015, str. 28).
Commission Implementing Regulation (EU) 2015/404 of 11 March 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb (OJ L 67, 12.3.2015, p. 6).
Izvedbena uredba Komisije (EU) št. 844/2012 z dne 18. septembra 2012 o opredelitvi določb, potrebnih za izvedbo postopka podaljšanja odobritve aktivnih snovi, kot je določeno z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet (UL L 252, 19.9.2012, str. 26).
Commission Implementing Regulation (EU) 2015/415 of 12 March 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances ethephon and fenamiphos (OJ L 68, 13.3.2015, p. 28).
PRILOGA
Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).
Del A Priloge k Izvedbeni uredbi (EU) št. 540/2011 se spremeni:
ANNEX
v šestem stolpcu vrstice 15 se za dikvat datum veljavnosti registracije nadomesti s „30. junij 2019“;
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
v šestem stolpcu vrstice 23 se za pimetrozin datum veljavnosti registracije nadomesti s „30. junij 2019“;
in the sixth column, expiration of approval, of row 15, Diquat, the date is replaced by ‘30 June 2019’;
v šestem stolpcu vrstice 35 se za famoksadon datum veljavnosti registracije nadomesti s „30. junij 2019“;
in the sixth column, expiration of approval, of row 23, Pymetrozine, the date is replaced by ‘30 June 2019’;
v šestem stolpcu vrstice 37 se za metalaksil-M datum veljavnosti registracije nadomesti s „30. junij 2019“;
in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2019’;
v šestem stolpcu vrstice 39 se za flumioksazin datum veljavnosti registracije nadomesti s „30. junij 2019“;
in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2019’;
v šestem stolpcu vrstice 42 se za oksasulfuron datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2019’;
v šestem stolpcu vrstice 44 se za foramsulfuron datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 46 se za ciazofamid datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 62 se za fenamidon datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 63 se za izoksaflutol datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 78 se za klorprofam datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 83 se za alfa-cipermetrin datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 78, Chlorpropham, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 84 se za benalaksil datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 85 se za bromoksinil datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 86 se za desmedifam datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 88 se za fenmedifam datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 96 se za metoksifenozid datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 97 se za S-metolaklor datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 96, Methoxyfenozide, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 98 se za Gliocladium catenulatum sev: J1446 datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 99 se za etoksazol datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 98, Gliocladium catenulatum strain: J1446, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 109 se za bifenazat datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 110 se za milbemektin datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 141 se za fenamifos datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 142 se za etefon datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 145 se za kaptan datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 146 se za folpet datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 147 se za formetanat datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 148 se za metiokarb datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 149 se za dimetoat datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 150 se za dimetomorf datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 152 se za metribuzin datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 153 se za fosmet datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 154 se za propamokarb datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 155 se za etoprofos datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 156 se za pirimifos-metil datum veljavnosti registracije nadomesti s „31. julij 2019“;
in the sixth column, expiration of approval, of row 155, ethoprophos, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 158 se za beflubutamid datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 163 se za bentiavalikarb datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 164 se za boskalid datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 165 se za karvon datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 166 se za fluoksastrobin datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 165, Carvone, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 167 se za Paecilomyces lilacinus sev 251 datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2019’;
v šestem stolpcu vrstice 168 se za protiokonazol datum veljavnosti registracije nadomesti z „31. julij 2019“;
in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2019’;
Obdobja odobritve navedenih snovi bodo prenehala veljati 30. junija 2018.
in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2019’.
Vloge za obnovitev vključitve navedenih snovi v Prilogo I k Direktivi Sveta 91/414/EGS so bile vložene v skladu s členom 4 Uredbe Komisije (EU) št. 1141/2010.
Commission Implementing Regulation (EU) 2018/919
Izvedbena uredba Komisije (EU) 2018/919
Commission Implementing Regulation (EU) 2018/920
Izvedbena uredba Komisije (EU) 2018/920
amending Implementing Regulation (EU) No 180/2014 as regards certain provisions on checks, notifications and annual reporting and on amendments to the POSEI programmes
o spremembi Izvedbene uredbe (EU) št. 180/2014 glede nekaterih določb o pregledih, obvestilih in letnem poročanju ter spremembah programov POSEI
Having regard to Regulation (EU) No 228/2013 of the European Parliament and of the Council of 13 March 2013 laying down specific measures for agriculture in the outermost regions of the Union and repealing Council Regulation (EC) No 247/2006, and in particular Article 6(2), the second paragraph of Article 8 and Articles 12(3) and 14(1) thereof,
ob upoštevanju Uredbe (EU) št. 228/2013 Evropskega parlamenta in Sveta z dne 13. marca 2013 o posebnih ukrepih za kmetijstvo v najbolj oddaljenih regijah Unije in razveljavitvi Uredbe Sveta (ES) št. 247/2006 in zlasti člena 6(2), drugega odstavka člena 8 ter členov 12(3) in 14(1) Uredbe,
Experience gained with the application of Commission Implementing Regulation (EU) No 180/2014 has shown that certain provisions relating to checks, notifications and annual reporting need to be clarified and simplified.
Izkušnje, pridobljene z uporabo Izvedbene uredbe Komisije (EU) št. 180/2014, so pokazale, da je treba nekatere določbe, ki se nanašajo na preglede, obvestila in letno poročanje, pojasniti in poenostaviti.